SEC Form 4 · accession 0001209191-19-006198
Verrica Pharmaceuticals Inc. · VRCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn A Oclassen
Director
Period of report
Jan 25, 2019
Accepted (ET)
Jan 31, 2019 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660334
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 25, 2019 | G | 150,000 | $0.00 | D | 140,421 | I | See Footnote |
| Common StockF1 | Jan 28, 2019 | G | 75,000 | $0.00 | D | 65,421 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held directly by The Glenn A. Oclassen 2016 Trust dated November 30, 2016 (the "Trust"). The Reporting Person serves as trustee of the Trust.